DE3785740T2 - Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie. - Google Patents

Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie.

Info

Publication number
DE3785740T2
DE3785740T2 DE87119319T DE3785740T DE3785740T2 DE 3785740 T2 DE3785740 T2 DE 3785740T2 DE 87119319 T DE87119319 T DE 87119319T DE 3785740 T DE3785740 T DE 3785740T DE 3785740 T2 DE3785740 T2 DE 3785740T2
Authority
DE
Germany
Prior art keywords
hyperlipemia
medicament
manufacture
treatment
carboxamide compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE87119319T
Other languages
English (en)
Other versions
DE3785740D1 (de
Inventor
Kazuhiko Tsutsumi
Tagui Sugimoto
Yoshihiko Tuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE3785740D1 publication Critical patent/DE3785740D1/de
Application granted granted Critical
Publication of DE3785740T2 publication Critical patent/DE3785740T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE87119319T 1986-12-29 1987-12-29 Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie. Expired - Lifetime DE3785740T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31326786 1986-12-29
JP62317246A JPH0651625B2 (ja) 1986-12-29 1987-12-14 高脂質血症治療剤

Publications (2)

Publication Number Publication Date
DE3785740D1 DE3785740D1 (de) 1993-06-09
DE3785740T2 true DE3785740T2 (de) 1993-10-21

Family

ID=26567502

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87119319T Expired - Lifetime DE3785740T2 (de) 1986-12-29 1987-12-29 Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie.

Country Status (5)

Country Link
US (1) US5081112A (de)
EP (1) EP0273444B1 (de)
JP (1) JPH0651625B2 (de)
KR (1) KR940000008B1 (de)
DE (1) DE3785740T2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651625B2 (ja) * 1986-12-29 1994-07-06 株式会社大塚製薬工場 高脂質血症治療剤
AU606808B2 (en) * 1988-06-29 1991-02-14 Otsuka Pharmaceutical Factory, Inc. Arylcarboxamide substituted by alkylphosphonates, process for preparing the same and a pharmaceutical composition containing the same
JP2584336B2 (ja) * 1989-05-30 1997-02-26 株式会社大塚製薬工場 カルボン酸アミド誘導体
JP2835545B2 (ja) * 1990-11-27 1998-12-14 株式会社大塚製薬工場 白内障予防及び治療剤
JP2835547B2 (ja) * 1991-12-25 1998-12-14 株式会社大塚製薬工場 糖尿病治療剤
TW260664B (de) * 1993-02-15 1995-10-21 Otsuka Pharma Factory Inc
ATE196145T1 (de) * 1993-06-17 2000-09-15 Otsuka Pharma Co Ltd Phosphonsäurediesterderivate
CA2147375C (en) * 1993-08-20 2003-02-11 Kazuyoshi Miyata Phosphonic diester derivatives
WO1997024360A1 (fr) * 1995-12-27 1997-07-10 Otsuka Pharmaceutical Factory, Inc. Derives de diester d'acide phosphonique
TW570799B (en) * 1998-02-17 2004-01-11 Otsuka Pharma Co Ltd The agent for preventing and curing fatty liver
CN1867554B (zh) * 2003-08-11 2011-07-06 弗·哈夫曼-拉罗切有限公司 具有邻-取代的苯基的哌嗪及其作为glyt1抑制剂的用途
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8637706B2 (en) * 2005-11-28 2014-01-28 Gtx, Inc. Nuclear receptor binding agents
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
CA2695583A1 (en) * 2007-08-13 2009-02-19 Metabasis Therapeutics, Inc. Novel activators of glucokinase
US9427418B2 (en) 2009-02-23 2016-08-30 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9624161B2 (en) 2009-02-23 2017-04-18 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
WO2013078413A1 (en) * 2011-11-22 2013-05-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulators of lipid storage
KR101432012B1 (ko) * 2013-02-19 2014-08-21 한국식품연구원 항비만용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073740A (en) * 1958-10-06 1963-01-15 Smith Kline French Lab Method of reducing cholesterol levels with tri- (dialkylaminoalkyl) phosphates
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
US4416877A (en) * 1979-02-13 1983-11-22 Symphar S.A. Anti-atherosclerotic pharmaceutical compositions containing diphosphonate compounds
GB2043073B (en) * 1979-02-13 1983-05-11 Symphar Sa Mono-and diphosphonate compounds
DE3564274D1 (en) * 1984-12-12 1988-09-15 Kanebo Ltd Novel ethyl benzylphosphinate derivatives, process for production thereof, and their use as calcium antagonist
JPS61151199A (ja) * 1984-12-26 1986-07-09 Otsuka Pharmaceut Factory Inc カルボン酸アミド誘導体
US4704382A (en) * 1985-07-29 1987-11-03 G. D. Searle & Co. Phenylpiperazine phosphonates
JPH0651625B2 (ja) * 1986-12-29 1994-07-06 株式会社大塚製薬工場 高脂質血症治療剤
US4822780A (en) * 1987-07-08 1989-04-18 Otsuka Pharmaceutical Factory, Inc. Carboxamide compounds

Also Published As

Publication number Publication date
JPH0651625B2 (ja) 1994-07-06
US5081112A (en) 1992-01-14
EP0273444A2 (de) 1988-07-06
KR880007085A (ko) 1988-08-26
EP0273444A3 (en) 1990-07-11
DE3785740D1 (de) 1993-06-09
EP0273444B1 (de) 1993-05-05
JPS63264421A (ja) 1988-11-01
KR940000008B1 (ko) 1994-01-05

Similar Documents

Publication Publication Date Title
DE3785740T2 (de) Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie.
DE68928783T2 (de) Zwischenverbindungen zur Herstellung von Fungiziden
DE122005000002I1 (de) Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
DE3585607D1 (de) Verwendung von paroxetine zur herstellung eines arzneimittel zur behandlung von obesitaet.
DE69019488D1 (de) Behandlung von Geflügel.
DE68927110T2 (de) Verfahren zur Herstellung von 1,1,1-Trifluoro-2,2-Dichlorethan
DE3788057T2 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
DE69018043T3 (de) Behandlung von Geflügel.
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE3782028D1 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE69233725D1 (de) Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
DE69005978T2 (de) Verwendung von Actinonin zur Herstellung eines Medikamentes zur Inhibierung der Angiogenese.
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE68905657T2 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3873210T2 (de) Verwendung von benzylpyridin-derivaten zur herstellung eines arzneimittels zur behandlung der demenz.
DE3873188D1 (de) Verwendung von nigerizin zur herstellung eines mittels zur behandlung von virus-erkrankungen.
DE3483944D1 (de) Verwendung von selektiv peripheren dopamin-antagonisten zur herstellung eines arzneimittels zur topischen behandlung von okularer hypertension.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE3785555T2 (de) Verwendung von guaifenesin zur behandlung urologischer beschwerden.
ATE11911T1 (de) N-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4amino-5-methylsulfamoyl-benzamide, verfahren zur herstellung und verwendung als heilmittel.
DD136834A5 (de) Verfahren zur herstellung von 2-(2',2'-dihalogenvinyl-und 2-(2',2',2'-trihalogenaethyl)-cyclobutanonen
DE3777709D1 (de) Verwendung von 3'azido-3'deoxythymidin zur herstellung eines arzneimittels zur behandlung von gardiasis.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
PT67628B (de) Verfahren zur herstellung von fungiziden mitteln mit 2,4-dichlorphenyl-triazolyl-athan-one-(-ole) und dessen physiologisch vertraglichen salze mit fungizide mittel
ATE58476T1 (de) Verwendung von doxaminol zur herstellung eines arzneimittels zur behandlung der peripheren arteriellen verschlusskrankheit.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition